30.04.2013 • News

Azelis Announces Refinancing Deal

Today, speciality chemicals distributor Azelis announces that it has successfully secured an amend and extend refinancing package to deliver the company's new business plan.  Under the new plan, the company's financing has been extended for a further 3 years at market interest rates. 

In addition, the company's main shareholder 3i, and funds managed by 3i, have provided further equity support of €10 million, representing a significant contribution for the benefit of Azelis. 

The deal reflects exceptional support from the banking community and from 3i for the new business plan and provides Azelis with strengthened liquidity and the financial resources to develop the business.

 

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read